HIV Malignancy Specimens for Research at No Charge
RFA-CA-22-001, U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) has been published. This is a reissuance of RFA-CA-20-001. The purpose of this Funding Opportunity Announcement …
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trials Not Allowed) Attention Biorepositories and Biospecimen Science Programs! The earliest submission date for this National Cancer Institute Funding Opportunity …
The U.S. National Cancer Institute (NCI)-funded AIDS and Cancer Specimen Resource (ACSR) is pleased to announce the release of the Young Investigator Pilot Award (YIPA) for Fall 2021. We welcome …
The purpose of this National Institutes of Health Funding Opportunity Announcement (FOA) is to support Implementation Science for Cancer Control in People Living with HIV (PLWH) in Low- and Middle-Income …
These National Institutes of Health (NIH) Funding Opportunity Announcements (FOA) solicit research to better understand the epidemiology & biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in …
To download a copy of the application form, click here.
The U.S. National Cancer Institute (NCI)-funded AIDS and Cancer Specimen Resource (ACSR) is pleased to announce the release of the Young Investigator Pilot Award (YIPA) for 2021. We welcome applications …
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- …
• Letter of Intent required by December 30, 2020• Proposals must be submitted via e-mail in PDF or MS Word by 5 PM EST, Friday, January 29, 2021 to ssilver@gwu.edu. …
